STAT | Reporting from the frontiers of health and medicine Follow STAT+: FDA staff and peptide enthusiasts set to clash at advisory panel FDA advisers are set to consider whether allowing compounding pharmacies to offer largely unproven peptides is a safer bet than the gray-market versions now in use. https://www.statnews.com/2026/07/23/fda-advisory-panel-peptide-safety-compounding-pharmacies/ statnews.com
